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Synopsis We propose that the exploitation of the bioactive properties of secondary metabolites (SMs) by animals can
provide a ‘‘treatment’’ against various challenges that perturb homeostasis in animals. The unified theoretical framework
for the exploitation of SMs by animals is based on a synthesis of research from a wide range of fields and although it is
focused on providing generalized predictions for herbivores that exploit SMs of plants, predictions can be applied to
understand the exploitation of SMs by many animals. In this review, we argue that the probability of SM exploitation is
determined by the relative difference between the cost of a homeostatic challenge and the toxicity of the SM and we
provide various predictions that can be made when considering behavior under a homeostatic perspective. The notion
that animals experience and respond to costly challenges by exploiting therapeutic SMs provides a relatively novel
perspective to explain foraging behavior in herbivores, specifically, and behavior of animals in general. We provide
evidence that animals can exploit the biological activity of SMs to mitigate the costs of infection by parasites, enhance
reproduction, moderate thermoregulation, avoid predation, and increase alertness. We stress that a better understanding
of animal behavior requires that ecologists look beyond their biases that SMs elicit punishment and consider a broader
view of avoidance or selection of SMs relative to the homeostatic state. Finally, we explain how understanding exploi-
tation of SMs by animals could be applied to advance practices of animal management and lead to discovery of new
drugs.
Introduction
Physiology and foraging behavior of herbivores are
partially governed by the presence of chemical
defenses, or secondary metabolites (SMs) in plants.
Many species of plants produce SMs that can inhibit
the growth of microbes, fungi, and other plants and
typically have negative physiological and behavioral
consequences following ingestion by animals; hence
they are often referred to as defenses. SMs ingested
by animals can cause loss of weight and failure of
organs, alter metabolic rates, reduce digestibility
of nutrients, compromise the expenditure of energy
and even result in death, depending on the type and
amount of SM consumed (Cheeke and Palo 1995;
Dearing et al. 2005; Sorensen et al. 2005c; Froberg
et al. 2007).
As SMs can be acutely or chronically toxic to
herbivores, many herbivores have developed
strategies that minimize the effects of the SMs they
consume. Complete avoidance is typically not
possible due to the ubiquity and diversity of SMs.
Therefore, herbivores, which we broadly define as
animals consuming plant matter (e.g., fruits, stems,
leaves, roots, bark), will use a combination of behav-
ioral and physiological mechanisms that minimize
concentration of the SMs in the blood and tissues.
For example, herbivores may consume small
amounts of a variety of plants so that toxic levels
of any single SM can be avoided (Freeland and
Janzen 1974; Provenza 1995, 1996; Dearing and
Cork 1999; McLean and Duncan 2006). Herbivores
may also ingest smaller, more frequent meals and
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thereby minimize the dose of SMs in any single meal
(Wiggins et al. 2003; Sorensen et al. 2005a). Finally
herbivores may reduce exposure to SMs through bio-
chemical mechanisms that limit the absorption and
distribution and maximize the metabolism and elim-
ination of ingested SMs (McLean and Duncan 2006;
Sorensen and Dearing 2006; Sorensen et al. 2006).
Given the potentially harmful consequences of
many SMs to herbivores, it is logical to hypothesize
that herbivores are deterred, not rewarded,
from ingestion of SMs (Sullivan et al. 2008).
Nevertheless, some animals intentionally consume
SMs and benefit from it. For example, humans
have a long history of exploiting the biological activ-
ity of SMs for medicinal purposes (Johns 1990;
Cotton 1996). Although indigenous peoples have a
much longer history of using medicinal plants, the
first written accounts of SMs for medicine are
contained in the Ebers papyrus, circa 1500 B.C.
(Klaassen 2001). Plant-based medicines continued
to be used throughout history, but it was only in
the 19th century that active SMs were isolated
and characterized. Some of the most influential
discoveries of SMs with therapeutic uses include
the isolation of morphine from poppies in 1820;
quinine from Cinchona bark in 1841; ephedrine
from Ephedra species in 1897 and tubocurarine
from Chondrodendron tomentosum in 1935 (Sneader
1996). SMs or their derivatives account for nearly
half of small-molecule New Chemical Entities
approved on the market since 1994 (Newman and
Cragg 2007), with others currently in clinical trials
(Butler 2008; Harvey 2008). Although the medicinal
use of SMs is well documented, humans are not
unique in the animal kingdom for exploiting SMs
for benefit (Huffman 2003, 2007a). Janzen (1978)
was the first field biologist to suggest animals
may benefit from SMs as anti-parasitic agents. In
his seminal paper, he provided numerous anecdotal
examples of self-medication with plants from a
diverse array of wild animals, including herbivores,
omnivores, and carnivores. More striking are the sci-
entific descriptions of nonhuman primates ingesting
plants with known pharmacologically active SMs,
possibly as treatment of parasitic disease. The ques-
tion that arises, is how a SM that presumably
evolved, at least in part, as a deterrent, would be
chosen by animals as a reward (Huffman and Seifu
1989; Sullivan et al. 2008)? Although ecologists have
described how insects with high resistance to SMs
can exploit SMs as cues for finding food, mates,
or sites for oviposition (Feeny 1992), there are few
explanations addressing why animals that have not
co-evolved with SMs would exploit SMs that are
potentially toxic.
We propose that the exploitation of SMs can be
explained through understanding the homeostatic
challenges animals face. All organisms are in a con-
stant battle to stay in a state of equilibrium, or
homeostasis, with their environment. For herbivores,
the homeostatic state can be perturbed by a diet that
can offer nutritional deficits and potentially toxic
SMs (Provenza and Villalba 2006). Several studies
demonstrate that homeostasis in herbivores can be
altered by ingestion of SMs. For example, herbivores
may have limited tolerance for SMs such that they
cannot consume enough plant matter to maintain
energy balance (Sorensen et al. 2005b,c). In addition,
the homeostatic state of herbivores may be perturbed
by internal or external factors, other than SMs,
that put pressure on the state of health. SMs may
provide the ‘‘treatment’’ for factors that challenge
the homeostatic state. The homeostatic perspective
suggests that selection of diet may be guided not
only by avoidance of SMs, but, in some cases, by
selection for SMs that ameliorate other challenges.
In this review, we describe the general conditions
in which potentially toxic SMs might be actively
chosen by herbivores and other animals whereby
homeostasis is achieved. We provide various predic-
tions that can be tested when considering foraging
behavior under a homeostatic perspective. Finally, we
explain how understanding exploitation of SMs by
animals could advance animal-management practices
and lead to discovery of new drugs.
Homeostatic perspective: establishing
the probability of exploitation of SMs
Imagine an herbivore in a tropical habitat. This
animal, like most, is infected with parasites that
impact immunity and deplete energy. It is also the
mating season and resources are needed for ensuring
reproductive success. In addition, the scent of a
predator is in the air, which elevates stress hormones.
These challenges can negatively affect the internal
balance of energy and nutrients and thus compro-
mise the health of the animal. The intake of proper
energy and nutrients can help animals return to
well-being, or homeostasis. Unfortunately, achieving
internal homeostasis through feeding is not a simple
task. Herbivores must meet demands for energy and
nutrients by choosing the ‘‘right’’ diet in an environ-
ment containing 25–50 plant species. These plants
differ in their concentrations of energy, protein,
minerals, vitamins, indigestible matter (e.g., fiber,
cellulose) and SMs. Plants contain nutrients that
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can lessen the costs of a challenge. In addition, the
SMs that are potentially toxic may, in certain doses,
alleviate the costs of many external challenges. For
example, many SMs and their derivatives are used by
humans to combat bacterial and parasitic infections,
cancer, and a variety of other ailments (Harvey
2008). Likewise, wild animals may exploit the bioac-
tive properties of SMs that provide ‘‘treatment’’ or
‘‘self-medication’’ for their own ailments (Huffman
1997, 2003).
The notion that animals experience and respond
to different physiological states by selecting plants
containing medicinal properties provides a relatively
novel perspective to explain foraging behavior in
animals. The ecological literature devoted to plant–
herbivore interactions is full of examples demon-
strating how selection of diet is driven by avoidance
of SMs (Freeland and Janzen 1974; Howe and
Westley 1988; Lindroth 1988; Freeland 1991;
McArthur et al. 1991; Rosenthal and Berenbaum
1992; Cheeke and Palo 1995; Dearing and Cork
1999; Foley et al. 1999; Karban and Agrawal 2002;
Dearing et al. 2005; McLean and Duncan 2006). We
aim to establish a theoretical framework, based on
various examples in the literature, suggesting that, in
some cases, animals exploit the bioactive properties
SMs and thereby mitigate challenges like infection,
reproduction and thermoregulation. We stress that
knowledge of the relative cost of each challenge
and toxicity of each SM is important in determining
the internal and external conditions that warrant
exploitation of SMs.
We predict that the likelihood of SMs being
exploited by animals as a natural treatment against
a challenge is dependent on both the cost of the
challenge and the therapeutic index of the SM in a
particular animal. The therapeutic index is defined
as the ratio between the concentration of a given
chemical resulting in toxicity and the concentration
providing therapy (American Heritage Medical
Dictionary, Fig. 1), and provides a general measure
of the toxicological cost for a chemical. The
therapeutic index of SMs consumed by herbivores
is influenced by the chemical properties of the SM
(e.g., solubility, size) and the capacity of the herbi-
vore to detoxify and eliminate the SM. In general,
if a SM is readily absorbed and has a slow rate of
detoxification and elimination, then very small
amounts of intake could result in concentrations in
the body that are toxic and the SM is likely to have
a narrow therapeutic index (Fig. 1). If, however,
the SM is not readily absorbed and the animal has
enzymes that rapidly detoxify and eliminate the SM,
then the SM is likely to have a wide therapeutic
index and may be considered less toxic (Fig. 1).
Drawing from the principles of the therapeutic
index, we can predict the probability that an
animal will exploit a SM for treatment of a particular
challenge. That probability is determined by the
relationship between the cost of a challenge and
the toxicity of the SM (Fig. 2). The cost of a
challenge is determined by the impact a challenge
has on the fitness of an animal, whereas toxicity is
determined by the therapeutic index of the SM in a
particular animal. For example, the cost of parasites
is expected to increase with increasing parasite load
and a SM is expected to have a wider therapeutic
index in the diet of a specialist herbivore than of a
generalist or an animal naı¨ve to that diet. The ulti-
mate ‘‘goal’’ for the animal is to regulate homeostasis
such that a balance is kept between minimizing the
cost of the challenge and minimizing toxicity. We
predict that SMs with a wide therapeutic index
could be exploited by animals incurring less costly
challenges, whereas SMs with a narrow therapeutic
Fig. 1 The therapeutic index (TI) of an ingested SM (or drug) is
dependent on the ratio between the therapeutic concentration
(dotted line) and the toxic concentration (dashed line) in a
particular animal. The concentration of any ingested SM (or drug)
following a feeding bout () increases as it gets absorbed, then
decreases as it gets metabolized and eliminated. (A) A theoretical
animal consuming an ideal dose of a SM in which concentrations
remain above the therapeutic concentration, but below the
toxic concentration, thus within the therapeutic window for the
longest period of time. (B) Two theoretical animals that differ in
their exposure to the same ingested dose of a SM with a narrow
TI. The solid grey curve represents an animal that has high
absorption and slow detoxification of the SM from a single
feeding bout resulting in concentrations that surpass toxicity
(dashed line). This animal should avoid the SM or consume very
small amounts even if it is therapeutic at some concentration.
The dash dotted grey curve represents an animal with lower
absorption and faster detoxification of this same SM resulting in
concentrations below toxicity. This animal may have several
feeding bouts () to achieve concentrations of the SM above the
therapeutic concentration for longer periods of time.
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index would be exploited by animals incurring more
costly challenges. Costs of challenges and toxicity are
dynamic and difficult to measure. Therefore, selec-
tion of diets by animals under varying challenges can
be used as an indicator of the relative costs of chal-
lenges and the toxicity of a SM (Fig. 2).
Evidence for SM exploitation related
to costs
Modern medicine provides the most obvious
evidence that exploitation of SMs by animals is
related to the cost of a challenge versus the thera-
peutic index of a SM. It may be supposed that a wide
therapeutic index is always essential for drug therapy
in humans, but this is not necessarily the case.
Cytotoxic drugs, like paclitaxel (a SM), are used to
treat life-threatening (i.e., high cost) cancers despite
their severe toxicity associated with a narrow
therapeutic index. In contrast, reduced alertness
(i.e., low cost) is widely treated with caffeine (a
SM) because of its inherently low toxicity associated
with a wide therapeutic index. We speculate that
herbivores may act similarly: more toxic SMs may
be consumed in desperate situations, whereas less
toxic SMs may be consumed in the alleviation of
noncritical challenges.
The following sections provide evidence that
animals exploit the biological activity of SMs to
mitigate the costs of parasitic infection and of repro-
duction and thermoregulation. We focus on these
challenges because they are costly and there is at
least one study demonstrating that animals can alle-
viate these challenges by exploiting the biological
properties of SMs. Animals may also exploit
SMs in reducing predation and mediating alertness.
We focus on exploitation of SMs by homeotherms
(e.g., mammals and birds) because they allow the
best inference with uses of SMs for similar challenges
in humans. Although herbivores are the most likely
animals to exploit SMs due to their natural associa-
tion with plants, we provide evidence that SMs
in plants and animals can be exploited both by
herbivores and nonherbivores.
Parasites
Ectoparasites
Ectoparasites represent the challenge most likely to
be treated by SMs because ectoparasites are costly
and animals do not actually ingest SMs to combat
ectoparasites and therefore minimize toxicity
(Fig. 2). Numerous studies have reported a cost of
ectoparasites on host reproductive success and sur-
vival (Combes 2001). In response, several animals
may reduce ectoparasite loads by exploiting SMs
from plants or insects. For example, mammals and
birds use the bioactive properties of leaves to line
nests and fumigate ectoparasites (Lafuma et al.
2001; Hemmes et al. 2002; Rajasekar et al. 2006).
Some animals apply the SMs from plants and insects
onto fur or feathers as a defense against ectoparasites
(Clayton and Vernon 1993; Douglas et al. 2001).
Other species obtain the bioactive SMs from plants
and animals in their saliva by chewing on chemically
defended plants and animals and then anointing fur
or feathers with their saliva (Weldon et al. 2003;
Huffman 2007b). We predict that the wide use of
SMs against ectoparasites by a variety of animals is
due to the low toxicity of SMs, afforded through low
levels of exposure to SMs by the host. The placement
of leaves in the nest or anointment of SMs to fur and
feathers does not involve ingestion, and thus the
chemical is not absorbed. It is possible that hosts
are exposed to SMs through inhalation of volatile
SMs in nests or absorption across the skin or in
the mouth during chewing. However, some plants
Fig. 2 The probability that an animal will exploit a SM is a
function of the relative cost of a challenge (e.g., parasites,
reproduction, thermoregulation) and the toxicity of a potentially
therapeutic SM. The wider the relative cost between the
challenge and the toxicity of an SM, the greater the probability
the SM will be exploited by an animal for self-medication against
the challenge. SMs with wide therapeutic indices (TI) are
considered to have lower toxicity than SMs with narrow TIs.
Darker shading represents higher probability of exploitation of
SMs. (A) A representative case in humans in whom lack of
alertness has a relatively low cost and the intake of caffeine
represents treatment with a relatively nontoxic SM due to a
wide TI. (B) A representative case in humans in whom cancer
represents a high-cost challenge and paclitaxel represents
treatment with a very toxic SM due to a narrow TI.
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do not contain volatile compounds and thus would
not be inhaled and exposure following topical or oral
absorption is expected to be much lower than
absorption across the gut. In cases in which ectopar-
asites are not costly (Munger and Karasov 1991;
Gallizzi et al. 2008; Heylen and Matthysen 2008),
we predict animals will not exploit SMs as there is
little benefit derived from the costs associated with
even low levels of SM exposure or costs incurred
by the process of obtaining nesting or anointment
material. However, as costs of ectoparasites increase
along a continuum, we predict that choice of certain
bioactive SMs will also change.
Endoparasites
Endoparasites represent another costly challenge,
as intestinal parasitic infection is the rule rather
than the exception in animals. Intestinal parasites,
specifically nematodes, negatively affect body condi-
tion and fecundity in animals (Irvine et al. 2006;
Reed et al. 2008). Intestinal parasites can be treated
by SMs such as condensed tannins that are ingested,
but not absorbed, and therefore may have low
toxicity in the host (i.e., wide therapeutic index).
The potentially high cost of infection and potentially
low toxicity of SMs that are not absorbed should
result in a large number of animals exploiting SMs
in treatment of intestinal parasites. Indeed, several
studies demonstrate that SMs with low absorption
are exploited. For example, parasitized lambs ingest
enough tannin, a type of SM that is not absorbed, to
reduce helminthoses (Lisonbee 2008; Lisonbee et al.
in review). In addition, sheep with parasite burdens
also manifest greater preferences for a tannin-
containing food, but not when infection is termi-
nated by dosing with ivermectin, an anti-parasitic
drug (Villalba et al. in review).
We predict that absorbed SMs will have the high-
est toxicity and should only be used when costs of
infection are highest and even then, they should
be consumed in small amounts. Although there is
very little empirical support for this prediction, the
combination of several separate studies suggest that
the exploitation of highly toxic SMs is rare and
only occurs in wild animals with severe parasite
challenges. For example, potentially therapeutic
plants are eaten only occasionally by chimpanzees
and typically in small amounts, but they increase
in frequency in the diet during months when rein-
fection by parasites responsible for reduced health
occurs (Huffman and Seifu 1989; Huffman 1997,
2003; Huffman et al. 1998). Moreover, some of the
plants exploited by primates only during times of
infection also treat blood-borne parasites, like
schistosomiasis, in humans, suggesting that these
plants contain SMs that are absorbed into the
blood (Ohigashi et al. 1994; Huffman et al. 1998).
Similarly, plant parts that are rarely eaten by the
Kanyawara group of chimpanzees in the Kibale
forest, Uganda (Krief et al. 2006) contain SMs with
significant anti-malarial activities (Krief et al. 2004).
The selective use of this plant, coupled with efficacy
against a blood parasite, suggests that this plant
contains SMs that are absorbed and potentially
toxic and would only be exploited by animals
under extreme parasitic challenges. These studies,
and many others (Huffman et al. 1993, 1996, 1998;
Huffman and Chapman 2009; Engel 2002), indicate
an association between exploitation of SMs and
infection and demonstrate the need for controlled
experimental studies.
Several experiments on domestic animals offer
guidance for the types of studies needed to empiri-
cally test exploitation of SMs for the treatment of
parasites. To date, studies on feeding have focused
on a single potential treatment for infection, such as
tannins. However, researchers should use combina-
tions of SMs found both within a single plant and
among plant species, not single SMs, as this is
natural choice for animals in the wild (Provenza
et al. 2003). Moreover, a combination of SMs from
mixed diets may better protect animals against a
range of parasites. Because parasites can evolve
resistance to any one anthelmintic, they are also
likely to do so with a single SM (Waller 2006).
Tannins, alkaloids, and terpenes each have anthel-
mintic effects by different mechanisms
(Hocquemiller et al. 1991; Kayser et al. 2003),
and may be more therapeutic against parasites in
combination than alone. We expect that the best
approach to treat infectious organisms with potential
resistance to single SMs is for animals to consume a
mix of plants with different SMs as a variety of SMs
may deliver active ingredients with multiple actions
on a broader array of parasites (Villalba and
Provenza 2007). We urge ecologists to test SM
exploitation in wild animals by carrying out future
feeding experiments in environments that contain
a variety of plants, each containing SMs with a differ-
ent therapeutic index (Villalba and Provenza 2007).
Reproduction
We hypothesize that animals are capable of exploit-
ing SMs that maximize or otherwise alter reproduc-
tive output (Huffman 1997). Costs of reproduction
can be great and are related to hormonal regulation,
metabolism, energy reallocation, impaired immunity,
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and production of defenses against stress and toxicity
(Harshman and Zera 2007). Given the importance of
reproduction for the survival of individual animals,
reproductive output needs to be maximized. The
majority of studies investigating SM intake related
to reproductive output indicate that SMs disrupt
reproduction. For example, phytoestrogens in many
plants bind to animal estrogen receptors and inhibit
folliclular development in females and decrease
fertility in males (Dixon 2004). Several plants also
contain SMs that are fetotoxic, resulting in abortions
and birth defects in offspring (Gardner et al. 1998;
Panter et al. 2002). These studies suggest that SMs
do not benefit animals.
However, there is evidence that SMs may be
used as cues in avoiding erroneous investment in
reproduction under limited availability of resources.
For example, SMs isolated from salt grass, naturally
consumed by montane voles, decrease uterine weight,
follicular development, and cause a cessation in
breeding in voles (Berger et al. 1977). SMs in salt
grass, and other grasses that suppress reproduction
by voles, are only produced at the end of the
vegetative growing season and thus provide cues
for an imminent reduction in resources. Studies
also suggest that animals may use SMs as cues to
initiate reproduction when resources are most
abundant (Leopold et al. 1976). For example,
6-methoxybenzoxazolinone (MBOA) in grass stimu-
lates reproduction in montane voles and its presence
coincides with the time of greatest availability of
food for rearing of pups (Berger et al. 1981;
Sanders et al. 1981).
Several studies also indicate that the intake of
SMs may actually benefit reproductive output. For
instance, tannins make protein unavailable for diges-
tion and absorption until it reaches the more acidic
abomasums of ruminants, thus enhancing nutrition
by providing high-quality protein to the small intes-
tines (Min et al. 2003). This bypass also enhances
immune responses and increases resistance to gastro-
intestinal nematodes in ruminants (Min et al. 2003,
2004). This immune effect, along with a resulting
increase in essential and branched-chain amino
acids, improves reproductive efficiency in sheep
(Min et al. 2001). Tannins may also improve fitness
of offspring. For example, intake of tannins by repro-
ducing lemurs resulted in increased milk production,
which may benefit offspring (Carrai et al. 2003).
In quail, isoflavones (SMs) in soy improved egg
quality (Sahin et al. 2007) and the intake of SMs
in rooibos tea increased body weight and egg
production of quail (Jurani et al. 2008).
Thermoregulation
Several lines of evidence suggest that animals can
also exploit SMs to maintain homeostatic body tem-
peratures. First, hypothermia (low body temperature)
and hyperthermia (high body temperature) can be
potentially lethal in homeotherms (Gentilello 1995;
White et al. 2007), like mammals, and therefore
represents a costly challenge. Second, many of the
physiological mechanisms used to maintain body
temperature within the thermoneutral zone can
be induced through SMs. For example, ingestion of
capsaicin and caffeine (both SMs) reduces body
temperature in a number of mammals (Ilback et al.
2007; Gavva 2008). The alkaloid from Wu-Chu-Yu, a
Chinese herb, can minimize heat stress in warmer
conditions by increasing heat loss and suppressing
heat production through vasodilatation (Tsai et al.
1995). Other SMs such as the alkaloids in tall
fescue and terpenes in pine trees can cause vasocon-
striction and prevent the loss of heat (Oliver et al.
1993; Gardner et al. 1998), thus providing a thermal
benefit in the cold. Finally, a recent study showed
that at least one species of mammal can minimize
the dissipation of heat through the intake of a nat-
ural diet containing SMs (McLister et al. 2004;
Dearing et al. 2008). Intake of juniper elevated
body temperature in woodrats. Furthermore, juniper
can reduce thermoregulatory costs for woodrats
acclimated to cold temperatures, whereas woodrats
acclimated to warm temperatures experience
increased thermoregulatory costs when consuming
juniper (McLister et al. 2004). In addition, woodrats
voluntarily consumed more juniper in the cold than
in the warm (Dearing et al. 2008). We speculate that
woodrats may exploit the SMs in juniper for warmth
without increased energetic costs. Furthermore,
we speculate that animals do not exploit plants to
override the highly conserved adaptation of thermo-
regulation, but rather to supplement thermoregula-
tion, such that SMs decrease the lower critical
temperature that elicits a thermoregulatory response.
This may be achieved through reduced heat loss via
vasoconstriction or through heat production via the
process of detoxification. We urge researchers to
consider both availability and thermal benefits or
consequences of SMs as factors that dictate choice of
diet as temperatures increase and decrease throughout
the season and in response to predicted increases in
temperature associated with climatic change.
Predation
Predation is extremely costly to animals as the end-
point of this challenge is death. Therefore, we expect
Exploitation of secondary metabolites 319
 at U
B K
iel on O
ctober 2, 2014
http://icb.oxfordjournals.org/
D
ow
nloaded from
 
less mobile animals that cannot readily flee from
predators will exploit SMs with potentially narrow
therapeutic indices (i.e., highly toxic) in reducing
predation. The most well-documented example of
SM exploitation as a defense against predators is
the ingestion and sequestration of SMs by herbivores.
Sequestration involves the bioaccumulation of
ingested SMs into the herbivore’s own tissues.
Sequestration of SMs as a defense against predators
is common in sedentary terrestrial animals (Duffey
1980; Camara 1997; Silva and Trigo 2002; Pasteels
and Hartmann 2004; Vlieger et al. 2004; Daly et al.
2007) and occurs in marine mesograzers (Paul and
Vanalstyne 1988; Pennings and Paul 1993), but is
rare in more mobile animals. To our knowledge,
there is only a single example of ingested SMs
being used by birds and mammals as defense against
predators. Pitohuis, a passerine bird, is thought
to sequester the alkaloid, homobatrachotoxin, from
beetles in their diet into the feathers and skin
(Dumbacher et al. 1992, 2004; Dumbacher 1999).
Exploitation of batrachotoxin has resulted in the
avoidance of this bird as food by natives of New
Guinea and likely deters other predators as well.
We predict that the paucity of examples of SM
sequestration in birds and mammals demonstrates
that other predator-avoidance strategies such as
cryptic behavior and physical ‘‘fight or flight’’
mechanisms are less costly than ingesting and
sequestering SMs in these mobile animals.
Moreover, body size, life span, metabolic needs and
detoxification capacity of avian and mammalian
herbivores may increase the costs associated with
ingesting and sequestering high concentrations of
SMs in tissues compared to the costs to insects.
Alertness
The stimulatory or depressant activities of SMs may
mitigate a variety of less costly challenges, such as
lack of alertness. Given the high cost of predation
(i.e., death), animals are expected to benefit from
maintaining a level of alertness (i.e., vigilance)
through increased ability to detect predators. In
addition, enhanced alertness may improve memory
of quality habitats and foods. Animals may enhance
alertness by consuming SMs that are stimulants.
Although scientific documentation of animals
affected by the stimulatory activities of plants is
rare, we provide examples from humans and anec-
dotal examples from wild animals as evidence that
SMs may enhance alertness.
Humans exploit SMs such as caffeine to increase
alertness and reduce reaction times (Michael et al.
2008) and these same SMs can improve performance
in nonhuman primates. For example, caffeine
allowed sleep-deprived marmoset monkeys to main-
tain psychomotor performance (van Vliet et al. 2008)
and nicotine increased attention and accuracy of
tasks in rhesus monkeys (Bain et al. 2003).
Although these studies do not investigate how SMs
might influence cognitive ability of animals in the
wild, there is anecdotal evidence that birds and
mammals use SMs as stimulants much as humans
do. One example from Africa stands out as perhaps
the best documented use by animals of SMs as
a stimulant. The plant, Tabernanthe iboga
(Apocynaceae), is used in religious rituals in
Cameroon (Pope 1969). Indigenous forest-dwelling
peoples reportedly discovered the hallucinogenic
properties of this plant by watching gorillas, wild
boars and porcupines digging up and eating the
roots, afterwards going into a wild frenzy (i.e., sti-
mulated). The active principle in iboga is ibogaine,
found in highest concentrations in the root. Ibogaine
affects the CNS and cardiovascular system, along
with tabernanthine and iboluteine, other active
constituents in the plant. The stimulating effects
are similar to caffeine and can increase stamina
(Dubois 1955; Szumlinski et al. 2001). Although
the initial effects of T. iboga may appear detrimental
(e.g., frenzy), as concentrations decrease below
hyperactive levels, animals may experience heigh-
tened alertness, similar to the effects of caffeine.
Although stimulants can improve alertness in
animals (Bain et al. 2003; van Vliet et al. 2008),
and animals appear to select plants containing
stimulants under some conditions (Huffman,
personal comm.), studies are needed to link the
exploitation of stimulatory SMs with improved
attention or performance in natural situations.
Homeostasis and self-medication in
humans
In the evolutionary perspective of SM–human inter-
actions, SMs may have been selectively used to treat
parasites, regulate neurotransmitter imbalances, or to
address periodic dietary deficiencies in nutritionally
constrained populations (Sullivan and Hagen 2002).
Humans, like wild animals, cannot escape the selec-
tion pressures from parasites. The global burden of
human disease resulting from helminth infections
is comparable to that of tuberculosis or malaria
(Mascie-Taylor and Karim 2003). Sullivan et al.
(2008) pointed out that two of the most widely-
used SMs today, nicotine (tobacco) and arecoline
(betel nut), have well-demonstrated anthelmentic
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properties in animals. They propose that the recre-
ational use of nicotine and arecoline could be an
evolved response to chronic parasitic infections in
ancestral human populations. The traditional exploi-
tation of SMs by humans may also have provided
some relief from the stresses associated with harsh
environmental conditions. Sullivan and Hagen
(2002) noted that most of the commonly-used SMs
today were originally exploited and domesticated
by indigenous groups living in marginal environ-
ments—for example khat in the deserts of northeast-
ern Africa, tobacco and coca in arid South American
desert and alpine regions, and betel nut in southeast-
ern Asian tropical rain forests. They also noted that,
from the ethno-historical perspective, all of these
SMs are stimulants used to manage hunger, fatigue,
and thermal stress, which are inherent challenges to
survival in inhospitable environments.
In humans, self-medication has been most closely
studied in clinical populations with high rates of
substance use such as depression and schizophrenia
(Sullivan and Hagen 2002). Khantzian (1997) has
proposed that self-medication in clinical population
functions to regulate affect states. In an alternative
model, Schneier and Siris (1987) have argued that
self-medication is a homeostatic self-regulation of
neurotransmitter imbalances. Specific examples of
self-medication using an unprocessed SM include
use of the indigenous betel-nut to ameliorate the
symptoms of schizophrenia in a clinical population
in Palau, Micronesia (Sullivan et al. 2007a, b). In an
apparent convergence of indigenous self-medication
and commercial drug development, xanomeline,
a synthetic analog of the betel-nut alkaloid arecoline
is currently in clinical trials as a novel agent for the
treatment of schizophrenia (Shekhar et al. 2008).
Testing for exploitation of SMs
We urge ecologists studying plant–herbivore interac-
tions, and animal behavior in general, to evaluate
whether animals may be exploiting SMs in their
environment to alleviate homeostatic perturbations
caused by a variety of external challenges. We
provide a sample of cases linking selective intake
of SMs by animals with coinciding challenges.
Additional examples will only be obtained if ecolo-
gists look beyond their biases that SMs elicit punish-
ment and instead consider avoidance or choice of
SMs relative to the homeostatic state. Ecologists
should consider the balance between the cost of
the challenge and the therapeutic index, or relative
toxicity, of SMs as they relate to foraging behavior.
The slow progress and acceptance of SM exploitation
by ecologists certainly stems from a lack of experi-
mental evidence. We recognize that the majority of
examples suggesting SM exploitation are correlative
and need experimental validation. We therefore offer
a guide for ecologists on how to best identify and
validate exploitation of SMs.
Ecologists should first focus on observations
of animal behavior under conditions that are most
likely to drive the evolution of exploitation of SMs.
For example, high levels of infection and high repro-
ductive or thermoregulatory stress result in desperate
conditions under which an animal will be more likely
to exploit a SM with potential for toxicity or therapy.
Specifically, animals with long-term associations with
SMs are more likely to exploit SMs for chronic
challenges. For example, insects that exploit SMs in
defending against predators typically have long-term
associations with the SM (e.g., dietary specialization).
These long-term associations are likely linked to
resistance via mechanisms that reduce absorption,
increase detoxification, or isolate SMs to specific
tissues, thus reducing the toxicity of the SM (i.e.,
wide therapeutic index) in the co-evolved insect.
We also predict that long-lived, social animals,
which frequently sample their environment, are
likely candidates to learn how to exploit SMs for
benefit. However, we predict that the ‘‘social
model’’ of exploitation may be rare, as it relies on
several complex factors. First, the SMs must have a
relatively wide therapeutic index, otherwise animals
would simply avoid the SM. Second, the intake of
the SMs with potentially therapeutic properties must
coincide with the challenge, thus sampling frequency
should increase with increasing challenge. Third, the
animal must associate the intake of a particular plant
with a reduced cost of a challenge, thus SMs that
provide an immediate treatment for the challenge
are more likely to be exploited. Forth, the animals
must be able to titrate the intake of an SM to remain
above the therapeutic concentration, but below the
toxic concentration (Fig. 1). Finally, conditions
should favor the transfer and maintenance of knowl-
edge of which SMs should be exploited to treat
specific challenges, e.g., in social animals that reside
in stable environments. We also urge researchers to
investigate the absorption, distribution, detoxifica-
tion and elimination of the SMs by the exploiter
(see Sotka et al. this issue and Sorensen et al.
2006) to verify that the SM is distributed to the
intestine or blood. Even small samples of the
blood, urine and feces can be sufficient to verify
the distribution of SMs or their derivatives. Studies
of biodistribution of SMs are needed to verify the
link between the intake of an SM, the concentration,
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and the subsequent toxicity or treatment of the
challenge.
Ecologists should consider conducting experimen-
tal studies to validate the exploitation of SMs.
Studies involving controlled feeding can be used to
investigate self-medication of natural SMs under
varying costs of the challenge while also varying
the therapeutic index of single SMs and combina-
tions of SMs or plants containing an array of SMs
for treatment. In addition, studies of feeding should
link the extent of absorption, detoxification and
potential toxicity of SMs and their derivatives to
the cost of various challenges. Finally, researchers
should be cognizant of how nutrients influence
homeostasis and interact with challenges and SM
toxicity (Raubenheimer 1992). Biochemical comple-
mentarities and sequence of ingestion both influence
the degree to which herbivores can titrate concentra-
tions of SM in relation to their homeostatic benefit
(Welch et al. 2009).
Broad application
The homeostatic perspective allows researchers to
maintain a holistic understanding of animal behavior
in response to costly challenges. By thinking of SMs
as a resource that can help animals maintain home-
ostasis, we are able to identify novel explanations for
foraging behavior. The homeostatic perspective will
advance our understanding of what drives foraging
behavior and the behavior of animals under challen-
ging insults. We now discuss how the homeostatic
perspective can also be broadly applied to improve
the management of animals and potentially lead to
discovery of new drugs.
Management of animals and landscapes
The major goal in agriculture is to maintain the
well-being of livestock while increasing food produc-
tion. One of the major challenges facing health and
production of livestock is parasites. Although
humans have used other approaches to reduce
parasites, including grazing management, biological
control, nutritional supplementation, vaccination,
and selective breeding (Stear et al. 2007), they have
come with mixed results, and none incorporate the
homeostatic perspective: that herbivores can meet
their nutritional needs and potentially combat para-
sites themselves if provided with biochemically
diverse foods. Given the evidence that animals can
benefit from SMs (e.g., reduced parasite loads), we
propose that management practices should offer
animals a variety of forages that differ in primary
and secondary metabolites. The ability to choose
foods enables livestock in confinement, on pastures,
and on extensive landscapes to better meet needs for
nutrients and to regulate intake of SMs (Provenza
et al. 2003, 2007). Providing diverse food options
may also benefit wild and captive animal popula-
tions. On the island of Bali in Indonesia, a free-
ranging population of temple monkeys in the Ubud
Sacred Monkey Forest is periodically fed papaya
leaves by park staff, a dietary change believed to be
responsible for the population’s parasite-free status
(Aida Rompis, DVM, personal communications to
MA Huffman). Although the direct link between
the intake of papaya leaves and the lack of infection
by parasites is speculative, monkeys at other sites in
Bali that do not receive these leaves have high
parasite loads (Aida Rompis, DVM) and the use of
papaya by indigenous peoples as a treatment for
parasites (malaria, amebiasis, intestinal helminths),
digestive upsets, and as an antiseptic (Iwu 1993),
strengthens these claims. These studies suggest that
the health of livestock and wildlife could be
improved by an appreciation for both the toxic
and beneficial properties of SMs in diverse foods.
Overlap with exploitation of SMs by humans
There is substantial overlap between both the
explanation for SM exploitation and the fate and
mechanism of action of SMs in humans and animals.
First, it is in the best interest of both humans and
animals to maintain homeostasis. Second, humans
experience costs of parasites (Pullan and Brooker
2008), reproduction (Reed et al. 2008) and thermo-
regulation (Gentilello 1995). Third, humans exploit
many of the same plants as treatments for the same
challenges as do animals (Huffman et al. 1998).
For example, the SMs in juniper thought to provide
thermal benefits to woodrats in the winter through
reduced heat dissipation are the same SMs in
turpentine that are used to induce hyperthermia in
humans (Hernandez-Espinosa et al. 2007). In
addition, there are many examples of plants whose
medicinal value to humans was discovered by obser-
ving self-medication in wild animals (Huffman
2007a), further revealing the similarities between
humans and animals. Finally, there is conservation
of the mechanisms used to absorb and detoxify
SMs across species (Saier and Paulsen 2001;
Sorensen and Dearing 2006). Furthermore, the
genetic conservation of receptor targets across species
means that SMs may bind to the same receptor tar-
gets in a variety of species, thus enabling many
animal models to predict effects of drugs on
humans (McGrath and Li 2008). For example, the
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cannabinoid receptors are not only highly conserved
in vertebrates, but their function (e.g., in reproduc-
tion and neurotransmission) and ligands are similar
across species (Lam et al. 2006; Chianese et al. 2008).
This overlap in use and mechanisms of action of
SMs allows the knowledge of the exploitation of
SMs in animals to advance discovery of drugs.
Discovery of bioactive SMs
Modern discovery of drugs is based on the
identification of generally small molecules that
either inhibit, activate or otherwise modulate a
certain macromolecule (e.g., protein, enzyme, recep-
tor) crucial for a given pathogenic condition (Koehn
and Carter 2005). Organisms from microbes to
humans share a great deal of biochemical architec-
ture. In particular, proteins (e.g., primary metabo-
lites) can be found in all organisms in one form or
another, although their homologies might differ
slightly. Because many SMs are believed to have
evolved within the context of their interaction with
the proteins of both lower (bacteria–fungi) and
higher organisms (herbivores) at the biochemical
level in ways that deter predators (e.g., binding to
taste receptors) or inhibit the growth of a competing
organism (e.g., direct toxicity), they are able to inter-
act with human proteins bearing a homologous
domain, active site or regulatory region. This
evolutionary history makes SMs ‘privileged struc-
tures’ and underlies their drug-like properties and
high biomedical potential. SMs are more similar in
their chemical diversity to current drugs on the
market than are compounds obtained through com-
binatorial chemical synthesis (Feher and Schmidt
2003; Koehn and Carter 2005; Larsson et al. 2007).
Thus, despite the significant advances in organic
chemistry and the availability of large libraries of
synthetic chemicals, SMs are still an important
source for novel drugs (Newman and Cragg 2007;
Butler 2008; Harvey 2008).
Sessile organisms, such as plants or invertebrates
(e.g., larvae) that lack physical defense systems, and
thus rely on SMs as chemical defenses, are great
sources of new drugs. However, the immediate
question that arises is how to discover SMs that
have medicinal properties. There are several classical
approaches for choosing plants or other biological
material that may contain new SMs. In the random
approach, all available plants are collected for screen-
ing, irrespective of any previous knowledge of the
folkloric use of the plant. This is commonly used
when little information is available on the plant or
organism of interest. However, it is estimated that
there are more than 400,000 plant species worldwide
(Govaerts 2001) and, hence, many researchers and
pharmaceutical companies seek ways of reducing
the number of plants to be screened. Taxonomical
or chemotaxonomical approaches attempt to
focus screening within only certain plant genera
or plants containing certain classes of SMs.
The ethnopharmacological approach provides an
additional type of focused screening by giving
credence to existing oral or written information on
the traditional use of a plant against a human dis-
ease. This is a common approach in societies where
traditional medicines constitute an important form
of healthcare (Ayurveda, TCM, Campo Medicine;
also see Kingston et al. 1999; Lewis et al. 1999).
However, cultural, governmental and intellectual
property issues associated with exploiting ethnobota-
nical knowledge limits commercial interest in ethno-
medicine (Soejarto et al. 2005). Because therapeutic
compounds in nature are becoming increasing
difficult to discover by these traditional approaches
(Clardy and Walsh 2004), there is a pressing need
for novel ways to identify and screen diverse sets of
chemicals.
We propose that integrating the fields of ecology
(both physiological and chemical) and pharmacology
can provide an additional and efficient route to
discover medicinally active SMs. Much as ethno-
medicine relies on knowledge of traditional or indig-
enous health-care practices, the ‘‘Pharm-Ecology’’
approach relies on the identification, description
and knowledge of potentially valuable plant–animal
interactions. Broad understanding of the chemical
interactions between SMs and the physiological and
behavioral responses of herbivores to these com-
pounds may expedite discovery of drugs and provide
a better understanding of the mechanisms by which
bioactive molecules are therapeutic and/or toxic.
Although our ancestors responsible for many tradi-
tional medicines may have been practicing ecological
bioprospecting since ancient times, scientific
researchers have only recently embraced this
approach. As described earlier, many examples of
ecological bioprospecting exist in the study of pri-
mate behavior and of the ecology of parasites
(Huffman 1997, 2007b; Engel 2002). In addition,
the use of ecological theory in bioprospecting has
improved the success rate of discovering useful phar-
maceuticals in tropical plants (Coley et al. 2003;
Helson et al. 2008). With an enhanced awareness
of the possible usefulness of SMs for discovering
drugs, ecologists could highlight ‘‘case studies’’ of
plant–herbivore interactions, specifically the exploita-
tion of SMs, to alert pharmacologists to the presence
of potentially valuable leads for new drugs.
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Conclusion
Agronomists and ecologists alike have come to view
SMs as defenses against herbivory because SMs limit
intake. Thus, we know little about how herbivores
might benefit from SMs, despite their use by
humans for medicinal benefit. Using homeostasis to
understand the choice of diets and the behavior of
animals under various challenges provides a novel
perspective that goes beyond the traditional explana-
tions that foraging behavior is guided by selection for
nutrients and avoidance of SMs. This perspective
may explain dietary changes occurring under differ-
ent pressures arising from predation and infection,
during reproduction, under changing temperatures
and, potentially, at times requiring heightened
alertness. Examples of exploitation of SMs by ani-
mals, although often correlative, suggest that animals
may not always choose to avoid SMs, but may
actually exploit the biological activity of SM in
ways that reduce costly challenges. There is great
need for controlled studies that can strengthen
existing correlations and anecdotal evidence of the
exploitation of SMs and test predictions on how
exploitation of SMs by animals evolved. We recog-
nize that some systems will be more amenable than
others to experimental manipulations, but behavioral
ecologists should attempt to design studies of feeding
that provide a choice of potentially therapeutic SMs
under varying types and costs of challenges. We also
stress that studies should consider the therapeutic
index of SM in species of interest and remain
cognizant that the therapeutic index for the same
SM can vary across species due to differences
in the capacity to absorb, detoxify and eliminate
the SM and due to differences in receptor binding.
Understanding the probability of exploitation of
SM by animals can be used to make and test several
predictions:
(1) If animals consume a potentially toxic SM that is
normally avoided, then the cost of a particular
challenge is greater than the cost of toxicity from
the SM.
(2) The greater the cost of the challenge required
before consuming a SM with potentially thera-
peutic properties, the narrower the therapeutic
index is for that SM.
(3) The exploitation of SMs for less costly challenges
suggests that the SM has a very wide therapeutic
index in general or that the animal exploiting the
SM has high capacity to detoxify and eliminate
the SM such that the therapeutic index in the
exploiting animal is wide.
We hope this review encourages researchers to test
the various predictions we have proposed about the
exploitation SMs by animals and to consider how to
apply this new perspective and knowledge to advance
the management of animals and the discovery of
drugs.
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